The White Paper on 2025 China’s Probiotics Market focuses on two key areas, dual-chamber probiotics and clinical probiotics. It summarizes the definition and classification of probiotics, relevant policies and standards, industry development, market size, innovation trends and the future growth.
China’s probiotics market has gone through stages including early research and microbiome development, regulatory refinement and market cultivation. It has now entered a new phase driven by innovation and international expansion, forming a market of significant scale. With rising public health awareness and increasing R&D investment from enterprises, the market for both general probiotics and clinical probiotics continues to grow. Clinical probiotics are mainly distributed through hospitals and retail pharmacies, and is expected to develop further toward specialization and precision.
From a product innovation perspective, dual-chamber probiotics have emerged as a new format of probiotics products. The powder and liquid are stored separately to maintain probiotic viability, and consumers activate the product by pressing the cap to mix the two parts before drinking. This design helps prevent loss of activity during storage and allows the use of high-activity strains for a fresher product experience. With relatively high market potential and commercial value, dual-chamber probiotics are expected to support industry upgrades and the development of higher value-added products.
